Nalaganje...
Is the Testis a Chemo-Privileged Site? Is There a Blood-Testis Barrier?
The incidence of testicular cancer, primarily seminoma, has been increasing in many countries, including the United States. The testis is often the site of residual cancer after adequate treatment with systemic chemotherapy. The blood-testis barrier is commonly cited as the explanation for residual...
Shranjeno v:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MedReviews, LLC
2007
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1831524/ https://ncbi.nlm.nih.gov/pubmed/17396169 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|